Randomized Trials of Cancer Drugs Are For Yesterday
RCTs are expensive, slow and yield frustratingly limited information. (Nature Outlook)
Randomized Trials of Cancer Drugs Are For Yesterday Read More »
RCTs are expensive, slow and yield frustratingly limited information. (Nature Outlook)
Randomized Trials of Cancer Drugs Are For Yesterday Read More »
Perhaps the literature fails to capture the clinical value of oncology drugs. This could happen for several reasons.
Actually, Many New Cancer Drugs May Be Helpful And Worth Trying Read More »
We need and can afford both: to raise the bar so that everyone has access to modern healthcare, and to
How The 21st Century Cures Act Should Support Public Health Read More »
Tomorrow’s doctors need to grasp more concepts in science and technology than did any previous generation of physicians.
To Educate Great Physicians, Focus On Science, Ethics And Future Learning Skills Read More »
Venetoclax is a powerful new kind of oral medication. It enables leukemia cells to die by interfering with Bcl-2, a
Over time, the costs should drop, like for smartphone tech, what my Dad – a chemistry major and retired physician
Precision Medicine Will (Eventually) Lower Cancer Care Costs Read More »